Cargando…
mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency
Tuberous sclerosis complex (TSC), caused by loss-of-function mutations in the TSC1 or TSC2 gene, is characterized by benign tumor formation in multiple organs. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) is the primary alteration underlying TSC tumors. By analyzing Tsc2-null...
Autores principales: | Li, Hongwu, Jin, Fuquan, Jiang, Keguo, Ji, Shuang, Wang, Li, Ni, Zhaofei, Chen, Xianguo, Hu, Zhongdong, Zhang, Hongbing, Liu, Yehai, Qin, Yide, Zha, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053737/ https://www.ncbi.nlm.nih.gov/pubmed/27078846 http://dx.doi.org/10.18632/oncotarget.8633 |
Ejemplares similares
-
Hyperactivated mTORC1 downregulation of FOXO3a/PDGFRα/AKT cascade restrains tuberous sclerosis complex-associated tumor development
por: Wang, Li, et al.
Publicado: (2017) -
TSC2 mediates hyperosmotic stress-induced inactivation of mTORC1
por: Plescher, Monika, et al.
Publicado: (2015) -
Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway
por: Zhang, Hui H., et al.
Publicado: (2009) -
Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
por: Carroll, Bernadette, et al.
Publicado: (2016) -
Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2
por: Li, Dapeng, et al.
Publicado: (2022)